Copyright
©The Author(s) 2017.
World J Gastroenterol. Jun 21, 2017; 23(23): 4200-4210
Published online Jun 21, 2017. doi: 10.3748/wjg.v23.i23.4200
Published online Jun 21, 2017. doi: 10.3748/wjg.v23.i23.4200
Table 1 Composition of warm microemulsion for cholesteryl butyrate and dexamethasone cholesteryl butyrate-solid lipid nanoparticles formulations
| Molar composition of warm microemulsion | Cb, mmol/L | DxCb-SLN, mmol/L |
| Dexamethasone 21-acetate | - | 8.1 |
| Cholesteryl butyrate | 273.7 | 273.7 |
| Epikuron™ 200 (purified phosphatidylcholine 92%) | 335.5 | 335.5 |
| Sodium glycocholate | 194.8 | 194.8 |
- Citation: Dianzani C, Foglietta F, Ferrara B, Rosa AC, Muntoni E, Gasco P, Della Pepa C, Canaparo R, Serpe L. Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: Effects in an in vivo model. World J Gastroenterol 2017; 23(23): 4200-4210
- URL: https://www.wjgnet.com/1007-9327/full/v23/i23/4200.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i23.4200